Results 21 to 30 of about 333 (103)

Management of Acne Vulgaris With Trifarotene [PDF]

Journal of Cutaneous Medicine and Surgery, 2023
Rajeev Chavda, Jerry Tan, Hilary Baldwin   +2 more
exaly   +2 more sources

Update of the EuroGuiDerm evidence-based guideline for the treatment of acne-Short version. [PDF]

J Eur Acad Dermatol Venereol
The 2025 EuroGuiDerm guideline update provides evidence‐based recommendations for acne management, addressing systemic antibiotics, systemic isotretinoin, hormonal therapies including spironolactone and contraceptives, and new topical agents. Key considerations include treatment duration, safety, pregnancy‐specific guidance and minimizing antibiotic ...
Nast A, Al Wattar BH, Beylot Barry M, Brüggemann H, Bukvić Mokos Z, Caruana DM, Degitz K, Dessinioti C, Dréno B, Driessen RJB, Gollnick H, Hædersdal M, Katoulis A, Läuchli S, Lambert J, Layton AM, Micali G, Ochsendorf FR, Sathyapalan T, Stangeland KZ, Thomsen SF, Töröcsik D, Pennitz A.   +22 more
europepmc   +2 more sources

A Comprehensive Review of Acne Treatments: Unpacking the Chemical Structures and Effective Bioactive Compounds. [PDF]

Health Sci Rep
ABSTRACT Background and Aims Acne vulgaris is a frequent skin disorder, affecting a large part of the population worldwide, and strongly influencing not only the physical but also the mental aspects of health. The choice of therapy for acne vulgaris is a very difficult one because the multifactorial causality of the disease and interindividual ...
Tajdari M, Abolghasemi S, Khanniri E, Bayanati M, Hakimimofrad R, Mahboubi-Rabbani M.   +5 more
europepmc   +2 more sources

Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series [PDF]

Dermatology and Therapy, 2022
Edward Lain, Andrew Alexis, James del Rosso   +2 more
exaly   +2 more sources

Patient Insights on Acne Hyperpigmentation, Trifarotene, and Skincare: 6-Month, LEAP Phase 4 Qualitative Exit Interview Findings. [PDF]

Patient
BACKGROUND: Acne-induced hyperpigmentation (AIH) has a considerable impact on patients\u2019 quality of life (QoL). In the phase 4 LEAP trial, patients treated with the topical retinoid trifarotene showed faster improvement in AIH compared to patients ...
Dias-Barbosa C, Taylor N, Chan K, York JP, Puelles J, Chavda R.   +5 more
europepmc   +2 more sources

Efficacy and Tolerability of Topical Trifarotene in Managing Acne Vulgaris Among Malaysians: A Single Arm, Open Label, Observational Study [PDF]

J Cosmet Dermatol
ABSTRACT Background Trifarotene is a new fourth‐generation topical retinoid that selectively binds to RAR‐γ receptors. However, the efficacy and safety data of trifarotene on Asians are lacking. Thus, we evaluated its real‐world efficacy and tolerability among Malaysians.
Goh J, Tan T, Ho W, Lee C, Sundaran M, An J, How K.   +6 more
europepmc   +2 more sources

Acne tarda: Recommendations for classification, treatment and care as a result of an expert discussion. [PDF]

J Dtsch Dermatol Ges
Summary Acne tarda is defined in the literature as adult acne, which according to most authors occurs in women aged 25 and older. However, the definitions and age groups vary depending on the study. Current guidelines rarely address adult acne. In this review, current studies and the literature on acne tarda are analyzed and evaluated by German experts.
Augustin M, Dirschka T, Gerber PA, Kerscher M, Kirsten N, Ochsendorf F.   +5 more
europepmc   +2 more sources

One Acne™: A holistic management approach to improve overall skin quality and treatment outcomes in acne with or without sensitive skin. [PDF]

Int J Dermatol
Abstract Acne and sensitive skin can take a profound toll on patients' well‐being, which can be exacerbated if the conditions are experienced together. This narrative review aims to identify appropriate treatments to facilitate a holistic management approach to acne (One Acne™), sensitive skin, and acne‐induced sequelae and describe the role of ...
Kircik L, Tan J, Lain ET, Beleznay K, Chavda R, Lachmann N, Brinkhuizen T, Baldwin H, Layton AM.   +8 more
europepmc   +2 more sources

Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study [PDF]

Dermatology and Therapy
Stephen Schleicher, Angela Moore, Elyse Rafal, Angelique Gagne-Henley, Sandra Marchese Johnson, Sunil Dhawan, Rajeev Chavda, J. P. York, Baldo Sforzolini, Kate Holcomb, Glynis Ablon, James Del Rosso, Brigitte Dreno   +12 more
doaj   +2 more sources

Table_4_Transcriptomics Analysis Indicates Trifarotene Reverses Acne-Related Gene Expression Changes.DOCX

, 2021
Background and Objectives: Trifarotene is a topical retinoid selective for retinoic acid receptor gamma that was recently approved for treatment of acne vulgaris.
Valerie Julia (11594533), Jayendra Kumar Krishnaswamy (9867420), Sandrine Blanchet-Réthoré (11594536), Brigitte Dreno (292705), Rajeev Chavda (9008731), Amir Khammari (149729)   +5 more
core   +1 more source